White Papers

CMS Changes Certain Pathology & Laboratory MUE's in Q3 Update

Each quarter CMS makes updates to Medically Unlikely Edits (MUE’s) for all CPT’s.  There are not always changes, but when there are, billing errors are prone to occur.  The July 1, 2018 MUE list did not just include updates to allowable units for a few Pathology and Laboratory HCPCS (80000-89999), but also the MUE Adjudication Indicator (MAI) for some codes.  The changes are as follows:

HCPCS Description MUE MAI New MUE New MAI
81479 Unlisted Molecular Path Code 1 Date of Service Edit:Clinical 3 Date of Service Edit: Clinical
87481 Candida Species, Amplified Probe Technique 1 1 Line Edit 2 Date of Service Edit: Clinical
88341 IHC Stain, Each Additional Single Antibody 9 1 Line Edit 13 Date of Service Edit: Clinical
88344 IHC Stain, Each Multiplex Antibody 1 1 Line Edit 6 Date of Service Edit: Clinical
88356 Morphometric Analysis, Nerve 1 1 Line Edit 3 Date of Service Edit: Clinical

Particularly noteworthy is the change to the MUE for IHC stains (88341 and 88344) and the MAI associated with each.  This changes claims submission and follow-up approaches in billing for these services.  The MUE Adjudication Indicator indicates that additional units can no longer be split by line item and modified with no limit to total number billed.  Instead, CMS is indicating that clinical standards are established for a given quantity of these stains and will expect documentation to support any amounts that exceed the established limit.  The MUE for 88342 remains at 3, with an MAI of Date of Service Edit: Clinical.

APS maintains tables in its proprietary billing system specific to CMS’ MUE’s and modifies claims prior to submission in order to allow for clean claim submission and payment.  Quarterly updates are in place to accommodate these changes. If you have questions about these changes, please contact your Practice Manager.

Recent White Papers

2020 Brings Your Payment Adjustment from the 2018 MIPS Performance Year
January 21st, 2020
LAB Act Passes: PAMA Reporting Delayed
January 21st, 2020
An Overview of Surprise Bill Legislation at the State Level
January 10th, 2020
The 2020 Medicare Final Rule
December 20th, 2019

Testimonials

APS has completely fulfilled all of our expectations, both in clinical pathology professional component billing and in all other areas of pathology billing.

Salt Lake City, UT

Are you ready to start seeing increased revenues? APS’ expertise and commitment to service can get you there.
Begin your partnership with APS Medical Billing.
Contact Us